vs
ADMA BIOLOGICS, INC.（ADMA）与null（SWIM）财务数据对比。点击上方公司名可切换其他公司
ADMA BIOLOGICS, INC.的季度营收约是null的1.4倍（$139.2M vs $100.0M），ADMA BIOLOGICS, INC.净利率更高（35.5% vs -7.0%，领先42.5%），ADMA BIOLOGICS, INC.同比增速更快（18.4% vs 14.5%），ADMA BIOLOGICS, INC.自由现金流更多（$34.6M vs $14.1M），过去两年ADMA BIOLOGICS, INC.的营收复合增速更高（30.4% vs -4.9%）
ADMA生物制剂公司是一家专注于研发、生产及商业化特种血浆来源免疫球蛋白疗法的生物制药企业，主要面向美国市场，为原发性免疫缺陷及其他免疫相关疾病患者、医护人员和医疗机构提供免疫健康领域的治疗方案。
该企业是一家源自美国的跨国律师事务所，1934年创立于加利福尼亚州洛杉矶，在诉讼业务、公司法务以及监管合规法律领域拥有深厚的行业积累与知名度，是全球颇具影响力的综合性律所之一。
ADMA vs SWIM — 直观对比
营收规模更大
ADMA
是对方的1.4倍
$100.0M
营收增速更快
ADMA
高出3.9%
14.5%
净利率更高
ADMA
高出42.5%
-7.0%
自由现金流更多
ADMA
多$20.5M
$14.1M
两年增速更快
ADMA
近两年复合增速
-4.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $139.2M | $100.0M |
| 净利润 | $49.4M | $-7.0M |
| 毛利率 | 63.8% | 28.0% |
| 营业利润率 | 45.1% | -10.7% |
| 净利率 | 35.5% | -7.0% |
| 营收同比 | 18.4% | 14.5% |
| 净利润同比 | -55.9% | 76.0% |
| 每股收益（稀释后） | $0.20 | $-0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ADMASWIM
| Q4 25 | $139.2M | $100.0M | ||
| Q3 25 | $134.2M | $161.9M | ||
| Q2 25 | $122.0M | $172.6M | ||
| Q1 25 | $114.8M | $111.4M | ||
| Q4 24 | $117.5M | $87.3M | ||
| Q3 24 | $119.8M | $150.5M | ||
| Q2 24 | $107.2M | $160.1M | ||
| Q1 24 | $81.9M | $110.6M |
净利润ADMASWIM
| Q4 25 | $49.4M | $-7.0M | ||
| Q3 25 | $36.4M | $8.1M | ||
| Q2 25 | $34.2M | $16.0M | ||
| Q1 25 | $26.9M | $-6.0M | ||
| Q4 24 | $111.9M | $-29.2M | ||
| Q3 24 | $35.9M | $5.9M | ||
| Q2 24 | $32.1M | $13.3M | ||
| Q1 24 | $17.8M | $-7.9M |
毛利率ADMASWIM
| Q4 25 | 63.8% | 28.0% | ||
| Q3 25 | 56.3% | 35.4% | ||
| Q2 25 | 55.1% | 37.1% | ||
| Q1 25 | 53.2% | 29.5% | ||
| Q4 24 | 53.9% | 24.6% | ||
| Q3 24 | 49.8% | 32.4% | ||
| Q2 24 | 53.6% | 33.1% | ||
| Q1 24 | 47.8% | 27.7% |
营业利润率ADMASWIM
| Q4 25 | 45.1% | -10.7% | ||
| Q3 25 | 38.0% | 13.3% | ||
| Q2 25 | 35.1% | 14.3% | ||
| Q1 25 | 30.4% | -4.4% | ||
| Q4 24 | 32.6% | -14.9% | ||
| Q3 24 | 33.1% | 8.9% | ||
| Q2 24 | 36.6% | 12.5% | ||
| Q1 24 | 26.7% | -1.9% |
净利率ADMASWIM
| Q4 25 | 35.5% | -7.0% | ||
| Q3 25 | 27.1% | 5.0% | ||
| Q2 25 | 28.1% | 9.3% | ||
| Q1 25 | 23.4% | -5.4% | ||
| Q4 24 | 95.2% | -33.4% | ||
| Q3 24 | 30.0% | 3.9% | ||
| Q2 24 | 29.9% | 8.3% | ||
| Q1 24 | 21.7% | -7.1% |
每股收益（稀释后）ADMASWIM
| Q4 25 | $0.20 | $-0.06 | ||
| Q3 25 | $0.15 | $0.07 | ||
| Q2 25 | $0.14 | $0.13 | ||
| Q1 25 | $0.11 | $-0.05 | ||
| Q4 24 | $0.45 | $-0.24 | ||
| Q3 24 | $0.15 | $0.05 | ||
| Q2 24 | $0.13 | $0.11 | ||
| Q1 24 | $0.08 | $-0.07 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $87.6M | — |
| 总债务越低越好 | $72.1M | $279.8M |
| 股东权益账面价值 | $477.3M | $405.9M |
| 总资产 | $624.2M | $823.2M |
| 负债/权益比越低杠杆越低 | 0.15× | 0.69× |
8季度趋势，按日历期对齐
现金及短期投资ADMASWIM
| Q4 25 | $87.6M | — | ||
| Q3 25 | $61.4M | — | ||
| Q2 25 | $90.3M | — | ||
| Q1 25 | $71.6M | — | ||
| Q4 24 | $103.1M | — | ||
| Q3 24 | $86.7M | — | ||
| Q2 24 | $88.2M | — | ||
| Q1 24 | $45.3M | — |
总债务ADMASWIM
| Q4 25 | $72.1M | $279.8M | ||
| Q3 25 | $72.4M | $281.1M | ||
| Q2 25 | — | $281.5M | ||
| Q1 25 | — | $306.9M | ||
| Q4 24 | $72.3M | $281.5M | ||
| Q3 24 | — | $282.8M | ||
| Q2 24 | — | $282.4M | ||
| Q1 24 | — | $282.8M |
股东权益ADMASWIM
| Q4 25 | $477.3M | $405.9M | ||
| Q3 25 | $431.2M | $408.4M | ||
| Q2 25 | $398.3M | $398.4M | ||
| Q1 25 | $373.4M | $381.1M | ||
| Q4 24 | $349.0M | $387.2M | ||
| Q3 24 | $231.9M | $416.6M | ||
| Q2 24 | $188.3M | $408.1M | ||
| Q1 24 | $153.7M | $391.8M |
总资产ADMASWIM
| Q4 25 | $624.2M | $823.2M | ||
| Q3 25 | $568.7M | $844.4M | ||
| Q2 25 | $558.4M | $822.1M | ||
| Q1 25 | $510.6M | $824.6M | ||
| Q4 24 | $488.7M | $794.2M | ||
| Q3 24 | $390.6M | $853.4M | ||
| Q2 24 | $376.4M | $830.0M | ||
| Q1 24 | $350.9M | $808.6M |
负债/权益比ADMASWIM
| Q4 25 | 0.15× | 0.69× | ||
| Q3 25 | 0.17× | 0.69× | ||
| Q2 25 | — | 0.71× | ||
| Q1 25 | — | 0.81× | ||
| Q4 24 | 0.21× | 0.73× | ||
| Q3 24 | — | 0.68× | ||
| Q2 24 | — | 0.69× | ||
| Q1 24 | — | 0.72× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $35.6M | $23.3M |
| 自由现金流经营现金流 - 资本支出 | $34.6M | $14.1M |
| 自由现金流率自由现金流/营收 | 24.8% | 14.1% |
| 资本支出强度资本支出/营收 | 0.8% | 9.2% |
| 现金转化率经营现金流/净利润 | 0.72× | — |
| 过去12个月自由现金流最近4个季度 | $27.8M | $38.0M |
8季度趋势，按日历期对齐
经营现金流ADMASWIM
| Q4 25 | $35.6M | $23.3M | ||
| Q3 25 | $13.3M | $51.0M | ||
| Q2 25 | $21.1M | $36.0M | ||
| Q1 25 | $-19.7M | $-46.9M | ||
| Q4 24 | $50.2M | $6.2M | ||
| Q3 24 | $25.0M | $37.2M | ||
| Q2 24 | $45.6M | $52.4M | ||
| Q1 24 | $-2.2M | $-34.5M |
自由现金流ADMASWIM
| Q4 25 | $34.6M | $14.1M | ||
| Q3 25 | $-1.1M | $45.2M | ||
| Q2 25 | $18.7M | $29.1M | ||
| Q1 25 | $-24.4M | $-50.3M | ||
| Q4 24 | $47.5M | $-98.0K | ||
| Q3 24 | $24.0M | $33.2M | ||
| Q2 24 | $43.6M | $47.9M | ||
| Q1 24 | $-4.6M | $-39.9M |
自由现金流率ADMASWIM
| Q4 25 | 24.8% | 14.1% | ||
| Q3 25 | -0.8% | 27.9% | ||
| Q2 25 | 15.3% | 16.8% | ||
| Q1 25 | -21.2% | -45.2% | ||
| Q4 24 | 40.4% | -0.1% | ||
| Q3 24 | 20.0% | 22.1% | ||
| Q2 24 | 40.7% | 29.9% | ||
| Q1 24 | -5.6% | -36.0% |
资本支出强度ADMASWIM
| Q4 25 | 0.8% | 9.2% | ||
| Q3 25 | 10.7% | 3.6% | ||
| Q2 25 | 2.0% | 4.0% | ||
| Q1 25 | 4.1% | 3.1% | ||
| Q4 24 | 2.3% | 7.2% | ||
| Q3 24 | 0.9% | 2.7% | ||
| Q2 24 | 1.9% | 2.8% | ||
| Q1 24 | 2.9% | 4.8% |
现金转化率ADMASWIM
| Q4 25 | 0.72× | — | ||
| Q3 25 | 0.36× | 6.29× | ||
| Q2 25 | 0.62× | 2.25× | ||
| Q1 25 | -0.73× | — | ||
| Q4 24 | 0.45× | — | ||
| Q3 24 | 0.70× | 6.32× | ||
| Q2 24 | 1.42× | 3.95× | ||
| Q1 24 | -0.12× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ADMA
| ADMA Bio Manufacturing Segment | $123.1M | 88% |
| Other | $16.0M | 12% |
SWIM
| In Ground Swimming Pools | $50.2M | 50% |
| Covers | $37.0M | 37% |
| Liners | $12.7M | 13% |
